Navigation Links
Great Point Partners Completes Growth Equity Investment in Axiom Real-Time Metrics
Date:5/8/2019

Great Point Partners (“GPP”) today announced a growth recapitalization of Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services that are used to enhance the efficiency of Phase I, II and III clinical trials and observational studies. Axiom is a leading e-clinical technology company that focuses on Electronic Data Capture (“EDC”), Data Management (“DM”), Clinical Trial Management Systems (“CTMS”), Randomization (“IWRS”), Electronic Patient Reported Outcomes (“ePRO”) and other technology and service solutions for biotechnology and pharmaceutical sponsors conducting clinical trials. Founded in 2001 and based in Toronto, Canada, the Company will leverage this funding to scale its technology system and superior customer service.

“From the beginning of our conversation when they proactively approached us about a partnership, Great Point demonstrated its expertise in the clinical trial service needs of biotechnology and pharmaceutical companies, Axiom’s core customer base. Their market knowledge and the depth of their experience investing in pharmaceutical services companies made them an ideal partner for Axiom as we enter our next phase of growth. GPP’s investment will allow Axiom to increase the level of customer service and add additional technology solutions and services,” said Andrew Schachter, Founder and CEO of Axiom.

“We are excited to partner with the Axiom team and help them execute an accelerated growth plan,” said Noah Rhodes, Managing Director at Great Point Partners. “Andrew and his team have built an impressive business that has been growing at 56% per year over the last six years. We look forward to introducing Andrew to the biotechnology CEOs in our network, all of whom are either current or potential customers for Axiom’s products and services.”

“Our work in the trenches alongside drug developers over the last decade has proven that there is a huge need for Axiom’s solutions. This need is reflected in their explosive growth and superb customer satisfaction reported to us by the CEOs who are their customers,” said Eddie Hjerpe, Senior Associate at Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, Conn., is a leading health care investment firm with approximately $1.6 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III, which has committed capital of $280 million. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III, $280 million in committed capital) and public equity funds (BMVF, approximately $1.1 billion). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at 203-971-3300 or http://www.gppfunds.com.

About Axiom Real-Time Metrics

Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: Data Management, Data Analytics, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and more than 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.

Read the full story at https://www.prweb.com/releases/great_point_partners_completes_growth_equity_investment_in_axiom_real_time_metrics/prweb16297121.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. VetStem Biopharma is Pleased to Share the Success Story of Jack, a Great Pyrenees who was Treated with Stem Cell Therapy by Dr. Andrea Hayes
2. NXT-IDs Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing"
3. Plant communities produce greater yield than monocultures
4. Study identifies gauntlet of obstacles facing migrating pronghorn in greater Yellowstone
5. Americans rate losing eyesight as having greatest impact on their lives
6. Expedition finds Nemo can travel great distances to connect populations
7. Small algae with great potential
8. Natura 2000 could do a great deal more for nature protection
9. Exposure to toxins makes great granddaughters more susceptible to stress
10. Fires above the Great Slave Lake in Canada
11. Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canadas standards for ozone air pollution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/6/2019)... ... June 05, 2019 , ... MedTech ... the global health and medical technology market, announced that it has selected Medacta ... Robotics Solution” award in the 2019 MedTech Breakthrough Awards program. , ...
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... manufacturing of orthopedic medical devices, today announced Q1-19 revenues of $31M, up 12% ... combined with successful roll-out of strategic investments & operational excellence initiatives worldwide. , ...
(Date:6/4/2019)... ... 2019 , ... Most preclinical EEG visualization platforms offer tools ... based on variations of amplitude, frequency or spike train detection. In the clinic, ... the complexity and variability of the signal, and automation tools are used only ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative Medicine ... (PSC) , has announced that their GMP facility for cell production is now ... manufacturing. This is an important milestone for VetStem as it expands into ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... regulatory thinking on Data Integrity on July 08-09, 2019 in Boston, MA. This ... biotech and medical device organizations. , The training will kick off with a ...
(Date:5/15/2019)... HERSHEY, Pa. (PRWEB) , ... May 15, 2019 , ... ... the Year in recognition for his work within the biomedical industry, where he is ... and improved medical devices. , “William Harding epitomizes the vision of our founders ...
(Date:5/7/2019)... Columbia (PRWEB) , ... May 06, 2019 , ... ... a go-to resource for the growing number of repositories being asked to store ... are grateful to the team of contributors who are world leaders, who have ...
Breaking Biology Technology: